February 15, 2022

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.

November 17, 2022

According to a report in early 2022 from the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes, which is more than 11% of the population. Diabetes was the seventh leading cause of death in the United States in 2017 based on the death certificates in which diabetes was listed as the underlying cause of death. A newly launched University of Cincinnati partnership is aiming to put a dent in those numbers in Greater Cincinnati.

February 22, 2021

Shaina Horner, a clinical researcher in the Division of Infectious Diseases used her connections in the local Latinx community to help recruit a diverse population for the Moderna COVID-19 vaccine trial.

November 28, 2022

A new study from the University of Cincinnati examined the impact of workplace stress and provided insights for organizations to explore ways to reduce workplace stress for a better and healthier working environment. The study had two parts: a survey in which respondents described their experiences of workplace stress during the COVID-19 pandemic and a quantitative study using saliva cortisol as a biomarker of stress along with a stress diary to find out where and when workplace stress commonly occurred.

May 23, 2023

Research out of UC examines the impact of stress during pregnancy on natal neurodevelopment. Spectrum News interviewed Anna Ruehlmann, PhD, of the Department of Environmental Health and Public Health Sciences at the UC College of Medicine about the study which she led.

August 25, 2022

One of the major roadblocks in the fight against the spread of COVID-19 in the early days of the pandemic was people refusing to get vaccinated against the virus. New research at UC examines that vaccine hesitancy and provides key insights into the behaviors and perceptions of the U.S. population during a critical time of the COVID-19 pandemic, just as vaccines were becoming more available.

October 17, 2022

Treatments for pulmonary arterial hypertension (PAH) — a type of high blood pressure that affects arteries in the lungs and in the heart — have improved significantly over the past 15 to 20 years and researchers at the University of Cincinnati have been at the forefront of those improvements. The result of a series of studies UC researchers were part of have allowed new medications to come to market for patients with PAH.

September 21, 2022

UC is one of 36 sites part of the GRADE study comparing different diabetes medicines. The study is going to be published in the New England Journal of Medicine.

December 13, 2022

Initial data from a University of Cincinnati clinical research study aimed at increasing diet quality and decreasing cardiovascular risk shows positive results. The study, called Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN), was a randomized, controlled trial that promotes a heart-healthy diet through nutrition counseling provided by a supermarket-based, registered dietitian within one of each participant’s home grocery stores.

June 17, 2020

Researchers at the University of Cincinnati and UC Health will host a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2. UC is one of approximately 90 sites across the United States selected for the study, which will administer the vaccine candidate mRNA-1273 to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19.